They implanted the device containing bone building drugs in the body of patients and found that the device successfully delivered the drug for 20 days with the help of radio signals.
“You could literally have a pharmacy on a chip,” says Langer, the David H. Koch Institute Professor at MIT. “You can do remote control delivery, you can do pulsatile drug delivery, and you can deliver multiple drugs.”
"These data validate the microchip approach to
multi-year drug delivery without the need for frequent injections, which can
improve the management of many chronic diseases like osteoporosis where
adherence to therapy is a significant problem," said study lead author Robert Farra, MicroCHIPS President and
Chief Operating Officer. "We look forward to making further progress
to advance our first device toward regulatory approvals, as well as developing
a range of products for use in important disease areas such as osteoporosis,
cardiovascular disease, multiple sclerosis, cancer, and chronic pain."
Source:
SayPeople
Via:
MIT
MicroCHIPS
No comments:
Post a Comment